Premium Nahrungsergänzungsmittel | artgerecht

Pancreatic Hormone Regulation – Insulin & Glucagon

Pancreatic hormone regulation describes how the pancreas controls the release of hormones such as insulin and glucagon to maintain stable blood sugar levels.

Regular tips about health Regular tips about health

Things worth knowing about "Pancreatic hormone regulation"

Pancreatic hormone regulation describes how the pancreas controls the release of hormones such as insulin and glucagon to maintain stable blood sugar levels.

What is Pancreatic Hormone Regulation?

Pancreatic hormone regulation refers to the complex mechanisms by which the pancreas controls the secretion of its hormones into the bloodstream. The pancreas serves two major functions: an exocrine function (producing digestive enzymes) and an endocrine function (releasing hormones directly into the blood). The hormonal regulation of the pancreas is essential for maintaining stable blood glucose levels and ensuring adequate energy supply throughout the body.

The Islets of Langerhans: Center of Hormone Production

The hormone-producing cells of the pancreas are grouped into structures called the islets of Langerhans (insulae pancreaticae). These account for approximately 1–2 % of the total pancreatic mass and contain several distinct cell types:

Beta cells (ß-cells): Produce insulin and amylin. They represent the largest proportion of islet cells (approximately 60–80 %).
Alpha cells (α-cells): Produce glucagon (approximately 15–20 % of islet cells).
Delta cells (δ-cells): Produce somatostatin, which inhibits the release of both insulin and glucagon.
PP cells: Produce pancreatic polypeptide, which influences gastric juice and enzyme secretion.
Epsilon cells: Produce ghrelin, a hormone involved in appetite regulation.

The Key Pancreatic Hormones and Their Functions

Insulin

Insulin is the body's primary blood glucose-lowering hormone. It is secreted by beta cells when blood glucose levels rise -- for example after a meal. Insulin enables the uptake of glucose into cells (especially muscle and fat cells), promotes glycogen storage in the liver, and inhibits the breakdown of glycogen (glycogenolysis) as well as the formation of new glucose (gluconeogenesis).

Glucagon

Glucagon acts as the antagonist to insulin. It is released by alpha cells when blood glucose levels fall (hypoglycemia) or during prolonged fasting. Glucagon stimulates the liver to break down glycogen and release glucose into the bloodstream, and promotes gluconeogenesis to restore blood glucose levels.

Somatostatin

Somatostatin from delta cells acts as a local regulator, inhibiting the secretion of both insulin and glucagon. It also slows gastric emptying and prolongs the absorption of nutrients from the intestine.

Amylin

Amylin is co-secreted with insulin from beta cells. It slows gastric emptying, suppresses postprandial glucagon release, and promotes satiety.

Regulatory Mechanisms of Pancreatic Hormones

The secretion of pancreatic hormones is controlled by multiple factors:

Blood glucose levels: The primary trigger for insulin secretion is an elevated blood glucose concentration. When blood glucose drops, glucagon secretion increases.
Amino acids: Certain amino acids (e.g., arginine, leucine) stimulate both insulin and glucagon secretion.
Incretins: Gut hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are released after food intake and amplify insulin secretion from beta cells.
Autonomic nervous system: The parasympathetic nervous system (vagus nerve) stimulates insulin secretion, while the sympathetic nervous system (activated during stress) promotes glucagon release and inhibits insulin secretion.
Somatostatin: Exerts local (paracrine) inhibitory effects on both insulin and glucagon secretion.

Clinical Relevance of Pancreatic Hormone Regulation

Disorders of pancreatic hormone regulation can lead to serious medical conditions:

Type 1 diabetes mellitus: Autoimmune destruction of beta cells results in an absolute deficiency of insulin.
Type 2 diabetes mellitus: Progressive insulin resistance in peripheral tissues combined with declining beta cell function leads to chronically elevated blood glucose.
Insulinoma: A benign tumor of the beta cells causing excessive insulin production and hypoglycemia.
Glucagonoma: A rare tumor of the alpha cells resulting in excess glucagon production.
Pancreatitis: Inflammation of the pancreas can impair hormone-producing cells and lead to secondary diabetes.

References

Kieffer, T.J. & Habener, J.F. (1999): The glucagon-like peptides. In: Endocrine Reviews, 20(6), 876–913. DOI: 10.1210/edrv.20.6.0385
Boron, W.F. & Boulpaep, E.L. (2017): Medical Physiology. 3rd Edition. Elsevier. Chapter: The Endocrine Pancreas.
World Health Organization (WHO) (2023): Diabetes. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.